Literature DB >> 24586216

Cardiovascular protection by β-blockade in hypertensive haemodialysis patients: the Hypertension in Haemodialysis Patients Treated With Atenolol or Lisinopril (HDPAL) trial.

Carmine Zoccali1, Francesca Mallamaci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24586216     DOI： 10.1093/ndt/gfu029

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  2 in total

1.  Cardiovascular disease in CKD in 2014: new insights into cardiovascular risk factors and outcomes.

Authors:  Pantelis A Sarafidis; George L Bakris
Journal:  Nat Rev Nephrol       Date:  2014-12-16       Impact factor: 28.314

2.  The effect of swimming exercise on adenine-induced kidney disease in rats, and the influence of curcumin or lisinopril thereon.

Authors:  Badreldin H Ali; Turan Karaca; Yousuf Al Suleimani; Mohammed Al Za'abi; Jamila Al Kalbani; Mohammed Ashique; Abderrahim Nemmar
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.